BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7770295)

  • 1. Efficacy of tryptophan for the treatment of nonketotic hyperglycinemia: a new therapeutic approach for modulating the N-methyl-D-aspartate receptor.
    Matsuo S; Inoue F; Takeuchi Y; Yoshioka H; Kinugasa A; Sawada T
    Pediatrics; 1995 Jan; 95(1):142-6. PubMed ID: 7770295
    [No Abstract]   [Full Text] [Related]  

  • 2. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
    Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G
    Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of NMDA antagonist interventions in the treatment of nonketotic hyperglycinemia.
    Deutsch SI; Rosse RB; Mastropaolo J
    Clin Neuropharmacol; 1998; 21(2):71-9. PubMed ID: 9579291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor.
    Schmitt B; Steinmann B; Gitzelmann R; Thun-Hohenstein L; Mascher H; Dumermuth G
    Neurology; 1993 Feb; 43(2):421-4. PubMed ID: 8437713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.
    Alemzadeh R; Gammeltoft K; Matteson K
    Pediatrics; 1996 Jun; 97(6 Pt 1):924-6. PubMed ID: 8657542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-ketotic hyperglycinemia].
    Kálmánchey R; Szücs L; Majtényi K; Liptai Z; Dobos M; Krause I; Nagy I
    Orv Hetil; 1995 Jan; 136(5):245-9. PubMed ID: 7772127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonketotic hyperglycinemia treated with strychnine, a glycine receptor antagonist.
    Gitzelmann R; Steinmann B; Otten A; Dumermuth G; Herdan M; Reubi JC; Cuénod M
    Helv Paediatr Acta; 1978 Feb; 32(6):517-25. PubMed ID: 344282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan therapy for non-ketotic hyperglycinaemia.
    Inoue F; Matsuo S; Yoshioka H; Takeuchi Y; Yamanaka H; Kodo N; Kinugasa A; Sawada T
    J Inherit Metab Dis; 1992; 15(3):399-401. PubMed ID: 1383606
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient neonatal nonketotic hyperglycinemia: a 13-year follow-up.
    Zammarchi E; Donati MA; Ciani F
    Neuropediatrics; 1995 Dec; 26(6):328-30. PubMed ID: 8719751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with nonketotic hyperglycinemia: biochemical findings and therapeutic approaches.
    Trijbels JM; Monnens LA; van der Zee SP; Vrenken JA; Sengers RC; Schretlen ED
    Pediatr Res; 1974 May; 8(5):598-605. PubMed ID: 4545188
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of glycine in the nonketotic form of hyperglycinemia.
    Ando T; Nyhan WL; Gerritsen T; Gong L; Heiner DC; Bray PF
    Pediatr Res; 1968 Jul; 2(4):254-63. PubMed ID: 5669662
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextromethorphan in nonketotic hyperglycinemia.
    Allen RJ
    Neurology; 1993 Nov; 43(11):2422-3. PubMed ID: 8110239
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient neonatal hyperglycinemia.
    Schiffmann R; Kaye EM; Willis JK; Africk D; Ampola M
    Ann Neurol; 1989 Feb; 25(2):201-3. PubMed ID: 2919871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan in a child with nonketotic hyperglycinaemia--a 6-year follow up.
    Schmitt B; Steinmann B
    Eur J Pediatr; 1998 Apr; 157(4):349-50. PubMed ID: 9578977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic trial of NMDA antagonist for a nonketotic hyperglycinemic infant].
    Imai M; Kitajima H; Tokoro T; Kubo M; Maekawa K
    No To Hattatsu; 1995 Jul; 27(4):327-9. PubMed ID: 7612297
    [No Abstract]   [Full Text] [Related]  

  • 17. Attempts at use of strychnine sulfate in the treatment of nonketotic hyperglycinemia.
    MacDermot KD; Nelson W; Reichert CM; Schulman JD
    Pediatrics; 1980 Jan; 65(1):61-4. PubMed ID: 7355037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia.
    Boneh A; Degani Y; Harari M
    Pediatr Neurol; 1996 Sep; 15(2):137-41. PubMed ID: 8888048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonketotic hyperglycinemia in a neonate.
    Sehgal V; Ramji S
    Indian Pediatr; 1998 Mar; 35(3):278-81. PubMed ID: 9707887
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia.
    von Wendt L; Similä S; Saukkonen AL; Koivisto M
    Pediatrics; 1980 Jun; 65(6):1166-9. PubMed ID: 7375243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.